All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a healthcare professional.

The PsOPsA Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy


Now you can personalise
your PsOPsA Hub experience!

Bookmark content to read later

Select your specific areas of interest

View content recommended for you

Find out more

The PsOPsA Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the PsOPsA Hub cannot guarantee the accuracy of translated content. The PsOPsA Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact
You're logged in! Click here any time to manage your account or log out.
You're logged in! Click here any time to manage your account or log out.

Local therapies

Local therapies

Local therapies include topical treatments and phototherapy. Topical medications are typically used as the first-line treatment for most patients with psoriasis affecting <5% body surface area. They may also be used as an adjunctive treatment in patients with more extensive disease. Topical therapies include emollients, corticosteroids, vitamin D analogs, retinoids, and calcineurin inhibitors. Phototherapy (UV irradiation) is recommended as a first-line treatment option in patients with moderate to severe psoriasis, or in those with localized disease but severe symptoms, targeting the hyperproliferative epidermis and T cells.

Save to your areas of interest